End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.74 CNY | +1.16% |
|
+3.57% | -39.80% |
Business Summary
Number of employees: 1,520
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Technical Services
64.9
%
| 319 | 46.8 % | 391 | 64.9 % | +22.32% |
Biopharmaceutical
26.2
%
| 159 | 23.2 % | 158 | 26.2 % | -0.59% |
Pharmaceutical Intermediate Production and Sales
8.1
%
| 201 | 29.4 % | 49 | 8.1 % | -75.69% |
In Vitro Diagnostics Reagent
0.8
%
| 4 | 0.6 % | 5 | 0.8 % | +20.69% |
Other
0.1
%
| 0 | 0.0 % | 0 | 0.1 % | +354.39% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 684 | 99.4 % | 602 | 100.0 % | -12.02% |
Foreign
0.0
%
| 4 | 0.6 % | 0 | 0.0 % | -98.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ya Chen
CEO | Chief Executive Officer | 52 | 16/11/04 |
Huang Chen
CHM | Chairman | 49 | 31/12/99 |
Han Zhen Xia
DFI | Director of Finance/CFO | 61 | 31/12/99 |
Jing Du
BRD | Director/Board Member | 40 | 31/12/02 |
Hua Dong Tang
BRD | Director/Board Member | 46 | 31/12/01 |
Kun Yang
IRC | Investor Relations Contact | - | - |
Sheng Qiang Li
PRN | Corporate Officer/Principal | 48 | 31/12/99 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Han Zhen Xia
DFI | Director of Finance/CFO | 61 | 31/12/99 |
Sheng Qiang Li
PRN | Corporate Officer/Principal | 48 | 31/12/99 |
Ya Chen
CEO | Chief Executive Officer | 52 | 16/11/04 |
Jia Feng Zhu
BRD | Director/Board Member | 55 | 27/09/15 |
Hua Dong Tang
BRD | Director/Board Member | 46 | 31/12/01 |
Ming Dong Ran
BRD | Director/Board Member | 49 | 21/01/21 |
Jie Yan
BRD | Director/Board Member | 59 | 11/12/18 |
Jing Du
BRD | Director/Board Member | 40 | 31/12/02 |
Man Qi Zhao
CHM | Chairman | 50 | 15/05/23 |
Hai Bing Zhou
BRD | Director/Board Member | 54 | 15/05/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 130,894,391 | 61,107,956 ( 46.68 %) | 0 | 46.68 % |
Company contact information
Wuhan Hiteck Biological Pharma Co., Ltd.
Hiteck Science & Technology Park Economic & Technological Dev Zone
430056, Wuhan
+
http://www.hiteck.com.cn![address Wuhan Hiteck Biological Pharma Co.,Ltd(300683)](https://cdn.zonebourse.com/static/address/64310351.png)
Sector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.80% | 391M | |
+55.55% | 816B | |
+41.17% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+13.57% | 238B | |
+1.51% | 222B | |
+13.67% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- 300683 Stock
- Company Wuhan Hiteck Biological Pharma Co.,Ltd